Reaxys Announces Finalists of the 2012 Reaxys PhD Prize

3 pages

English

Reaxys Announces Finalists of the 2012 Reaxys PhD Prize

Elsevier

Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

3 pages

English

Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

A propos
Informations
Extrait

Description

Reaxys Announces Finalists of the 2012 Reaxys PhD Prize PR Newswire NEUCHÂTEL, Switzerland, May 30, 2012 NEUCHÂTEL, Switzerland, May 30, 2012 /PRNewswire/ -- The Reaxys® PhD Prize awards original and innovative research in organic, organometallic and inorganic chemistry Reaxys today announced the 45 finalists for the 2012 Reaxys PhD Prize. This highly prestigious international prize is open to all students studying for (or having completed in the last 12 months) a PhD in chemistry. The prize recognizes research and publication excellence in organic, inorganic, and organometallic chemistry. All entries were reviewed by a board of more than 80 leading international chemists and judged for originality, innovation, importance to the field, applicability, rigor of approach and publication quality. "The Reaxys PhD Prize is the premier prize celebrating the very best research being performed by young chemists at the world's leading chemistry departments" said Dr. David Evans, Scientific Affairs Director at Reed Elsevier Properties SA. "We received over 350 submissions. These 45 finalists represent the chemistry stars of the future. Having seen the reviews and read the submissions I know that identifying this year's overall three winners from these finalists will be extremely tough for the Reaxys PhD Prize Committee".

Informations

Publié par	Elsevier
Nombre de lectures	16
Langue	English

Extrait

Reaxys Announces Finalists of the 2012

Reaxys PhD Prize

PR Newswire

NEUCHÂTEL, Switzerland, May 30, 2012

NEUCHÂTEL,

Switzerland

May 30, 2012

/PRNewswire/ --

The Reaxys® PhD Prize awards original and innovative research in organic,

organometallic and inorganic chemistry

Reaxys today announced the 45 finalists for the 2012 Reaxys PhD Prize. This

highly prestigious international prize is open to all students studying for (or

having completed in the last 12 months) a PhD in chemistry. The prize

recognizes research and publication excellence in organic, inorganic, and

organometallic chemistry. All entries were reviewed by a board of more than

80 leading international chemists and judged for originality, innovation,

importance to the field, applicability, rigor of approach and publication quality.

"The Reaxys PhD Prize is the premier prize celebrating the very best research

being performed by young chemists at the world's leading chemistry

departments" said Dr. David Evans, Scientific Affairs Director at Reed Elsevier

Properties SA. "We received over 350 submissions. These 45 finalists represent

the chemistry stars of the future. Having seen the reviews and read the

submissions I know that identifying this year's overall three winners from these

finalists will be extremely tough for the Reaxys PhD Prize Committee".

All finalists are invited to attend and present their work at the Reaxys PhD Prize

Symposium which will be held at the 244th ACS National Meeting & Exposition,

Sunday August 19 2012

, in

Philadelphia

USA

. A travel bursary will be

provided to support attendance and registration fees for the conference.

The final selection of the winners of the 2012 Reaxys PhD Prize, will be made by

the Reaxys PhD Prize Committee who are all members of the Reaxys Advisory

Board:

Prof. A. G. M. Barrett

, Imperial College London

Prof. B. M. Trost

, Stanford University

Prof. H. N. C. Wong

, Chinese University of Hong Kong

The three winners will be announced mid-June. Each of the winners will receive

$2000

check, and will be invited to give a paper at the 2012 Reaxys PhD Prize

Symposium.

This year's successful finalists are:

Crisita Atienza, (Princeton University), Marie-Gabrielle Braun, (Ecole

Polytechnique, Palaiseau), Sarah Bronner, (University of California, Los

Angeles), David Bunck, (Cornell University), Yunfei Cai, (

Sichuan

University),

Mesut Cakmak, (Ludwig-Maximilian University of

Munich

), Andy Chapman,

(University of

Bristol

), Stefan Benson, (MaxPlanck Institut für Kohlenforschung/

Technical University Dortmund), Nicholas Evans, (University of Oxford), Charles

Frazier, (University of California, Santa Barbara), Niankai Fu, (Institute of

Chemistry, Chinese Academy of Sciences), Fang Gao, (Boston College), Thomas

Gøgsig, (

Aarhus

University), Gregory L Hamilton, (University of California, San

Francisco), Durga Prasada Rao Hari, (Universitaet Regensburg), Phillip Inglesby,

(University of Liverpool), Tomohiro Iwai, (Kyoto University), Justin Kim,

(Massachusetts Institute of Technology), Andrew Kyle, (University of Oxford),

Paraskevi Lagaditis, (University of Toronto), Chi Chung Lee, (University of

California, Irvine), Alastair Lennox, (University of

Bristol

), Zhi Li, (The University

of Chicago), Felicitas Lips, (University of Marburg), Min Lu, (Nanyang

Technological University), Jie Luo, (National University of Singapore), Matthew

R. MacDonald, (University of California, Irvine), Debashis Mandal, (

Nagoya

University), Steffen Müller, (University of Köln), Kei Murakami, (Kyoto

University), Kyungsu Na, (Korea Advanced Institute of Science & Technology),

Yuki Naganawa, (Kyoto University), Wesley Sattler, (Columbia University), Joerg

Schrittwieser, (University of

Graz

), Tae Ho Shin, (Kyushu University), Craig

Stivala, (University of California, Santa Barbara), Kenji Sumida, (University of

California, Berkeley), Basker Sundararaju, (Université de Rennes 1 , Rennes,

France

), Takayuki Tanaka, (Kyoto University), Ryo Tanaka, (The University of

Tokyo), Philipp Winter, (

Dortmund

University of Technology), Miao Yu, (Boston

College), Wei Zhang, (The University of Tokyo), Fangrui Zhong, (National

University of Singapore), Zhiwei Zuo, (Shanghai Institute of Organic Chemistry,

Chinese Academy of Sciences).

About Reaxys

Reaxys is a workflow solution for research chemists. Offering a wealth of

experimentally validated information, Reaxys combines reaction and substance

data in organic, organometallic, inorganic and physical chemistry with synthesis

planning. Researchers can get the information they need in a single overview,

from source publications carefully selected for their importance and relevance

to research chemists. Elsevier continues to engage with the chemistry

community to ensure that Reaxys continues to reflect how chemists think and

work. For more information please visit www.reaxys.com/info

Reaxys® is a trademark owned and protected by Reed Elsevier Properties SA

and used under license.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical

information products and services. The company works in partnership with the

global science and health communities to publish more than 2,000 journals,

including

The Lancet

and

Cell

, and close to 20,000 book titles, including major

reference works from Mosby and Saunders. Elsevier's online solutions include

SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's

Nursing Suite, which enhance the productivity of science and health

professionals, and the SciVal suite and MEDai's Pinpoint Review, which help

research and health care institutions deliver better outcomes more cost-

effectively.

A global business headquartered in

Amsterdam

, Elsevier employs 7,000 people

worldwide. The company is part of Reed Elsevier Group PLC, a world-leading

publisher and information provider, which is jointly owned by Reed Elsevier PLC

and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL

(London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Reed Elsevier Properties SA

Reed Elsevier Properties SA is a centre of excellence within Reed Elsevier for

the management, development and protection of intellectual property. Reed

Elsevier Properties SA owns the PharmaPendium and Reaxys databases.

Trademarks including Reaxys®, PharmaPendium®, Targetinsights™, The

Lancet® and World Travel Market® are owned and protected by Reed Elsevier

Properties SA and used under licence.

Media contact

Tom Reller

Vice President, Global Corporate Relations, Elsevier

+1-215-239-3508

t.reller@elsevier.com

Univers
Ebooks
Livres audio
Presse
Podcasts
BD
Documents

Reaxys Announces Finalists of the 2012 Reaxys PhD Prize

YouScribe

Le catalogue

Le service

Les conditions